[Experiences with Secabrevin in the postplacental period. A tocometric study].
D002317:Cardiovascular Agents; D004876:Ergot Alkaloids / Q000628:therapy*; D005260:Female; D006801:Humans; D010120:Oxytocics; D049590:Postpartum Period
D002317:Cardiovascular Agents; D004876:Ergot Alkaloids; D010120:Oxytocics
ERGOT ALKALOIDS/therapy; PUERPERIUM